ABC Transporters and Multidrug Resistance
Herausgegeben von Boumendjel, Ahcène; Boutonnat, Jean; Robert, Jacques
ABC Transporters and Multidrug Resistance
Herausgegeben von Boumendjel, Ahcène; Boutonnat, Jean; Robert, Jacques
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
This book gathers present knowledge on the involvement of ABC transporters in drug transport and resistance. Bringing together updated information from an otherwise scattered field of scientific literature, this resource helps researchers in pharmaceutical science in discovering drugs able to counteract multidrug resistance in diseases like cancer. It examines ABC transporters not only at the cancer cell, but also in other important physiological localizations. This book covers these topics as well as the pharmaceutical and medicinal modulation and inhibition of ABC transporters, helping…mehr
Andere Kunden interessierten sich auch für
- Philip RoweEssential Statistics for the Pharmaceutical Sciences125,99 €
- Rongshi LiKinase Drugs189,99 €
- Nicholas BodorRetrometabolic Drug Design and Targeting194,99 €
- Rosaleen AndersonAntibacterial Agents62,99 €
- Rosaleen AndersonAntibacterial Agents176,99 €
- Molecular Pathology in Drug Discovery and Development172,99 €
- Daniel LednicerAntineoplastic Drugs131,99 €
-
-
-
This book gathers present knowledge on the involvement of ABC transporters in drug transport and resistance. Bringing together updated information from an otherwise scattered field of scientific literature, this resource helps researchers in pharmaceutical science in discovering drugs able to counteract multidrug resistance in diseases like cancer. It examines ABC transporters not only at the cancer cell, but also in other important physiological localizations. This book covers these topics as well as the pharmaceutical and medicinal modulation and inhibition of ABC transporters, helping pharmaceutical researchers discover drugs to counteract multidrug resistance in diseases like cancer.
Produktdetails
- Produktdetails
- Wiley series in drug discovery and development
- Verlag: Wiley & Sons
- 1. Auflage
- Seitenzahl: 480
- Erscheinungstermin: 1. Juli 2009
- Englisch
- Abmessung: 236mm x 160mm x 25mm
- Gewicht: 755g
- ISBN-13: 9780470227343
- ISBN-10: 0470227346
- Artikelnr.: 26432391
- Wiley series in drug discovery and development
- Verlag: Wiley & Sons
- 1. Auflage
- Seitenzahl: 480
- Erscheinungstermin: 1. Juli 2009
- Englisch
- Abmessung: 236mm x 160mm x 25mm
- Gewicht: 755g
- ISBN-13: 9780470227343
- ISBN-10: 0470227346
- Artikelnr.: 26432391
Ahcéne Boumendjel is Professor of Medicinal Chemistry at the University of Grenoble School of Pharmacy, France. Jean Boutonnat is an Assistant Professor and Hospital Practitioner at the Grenoble Medical School and Université Joseph Fourier of Grenoble, France. Jacques Robert is Professor and Head of the Laboratory of Pharmacology of Anticancer Agents at Institut Bergonié and Université Victor Segalen Bordeaux 2, France.
PREFACE. CONTRIBUTORS. INTRODUCTION: WHAT IS MULTIDRUG RESISTANCE (Jonathan A. Sheps and Victor Ling). PART I ABC PROTEINS: AN OVERVIEW AND DESCRIPTION OF THE STRUCTURE
GENOME
NORMAL TISSUE EXPRESSION
PHYSIOLOGICAL ASPECT
AND MECHANISM OF ACTION. 1 The P-glycoprotein 170: Just a multidrug resistance protein or a protean molecule (Fabienne Grandjean-Forestier
Christophe Stenger
Jacques Robert
Mireille Verdier
and Marie-Hélène Ratinaud). 2 Multidrug resistance-associated protein (MRP/ABCC proteins) (Mylène Honorat
Charles Dumontet
and Lea Payen). 3 ABCG2: A new challenge in cancer drug resistance (Orsolya Polgar
Robert W. Robey
Kin Wah To
John Deeken
Patricia A. Fetsch
and Susan E. Bates). PART II ABC PROTEINS AND ONCOLOGY: EXPRESSION
DETECTION
AND IMPLICATION OF ABC PROTEINS IN HEMATOLOGICAL MALIGNANCIES AND SOLID TUMORS. 4 Expression
detection
and implication of ABC proteins in acute myeloblastic leukemia (Ollivier Legrand
Ruo-Ping Tang
and Jean-Pierre Marie). 5 ABC proteins and oncology: Expression
detection
and implication of ABC proteins in solid tumors (Jean François Bernaudin
Anne Fajac
Jocelyne Fleury-Feith
Khaldoun Kerrou
and Roger Lacave). PART III ABC PROTEINS AND PATHOGENIC MICROORGANISMS. 6 ABC transporters and resistance to antibiotics (Serge Michalet and Marie-Geneviève Dijoux-Franca). 7 ABC proteins involved in protozoan parasite resistance (Bruno Pradines). PART IV MULTIDRUG RESISTANCE (MDR) MODULATION THROUGH INHIBITION OF ABC TRANSPORTERS: DESIGN OF INHIBITORS AND MECHANISM OF ACTION. 8 Reversal agents for P-glycoprotein-mediated multidrug resistance (Hamid Morjani and Claudie Madoulet). 9 Reversal agents of multidrug resistance mediated by multidrug resistance-associated proteins (MRPs) (Ahcène Boumendjel
Anne Florin
and Jean Boutonnat). 10 Reversal agents for breast cancer resistance protein (BCRP)-mediated multidrug resistance (Jean Boutonnat
Anne Florin
and Ahcène Boumendjel). 11 Strategies to overcome drug resistance in acute and chronic leukemias (Eric Solary
Vincent Ribrag
and Stéphane de Botton). 12 Multidrug resistance reversal in solid tumors (Tatiana Bogush and Jacques Robert). PART V BIOLOGICAL AND CLINICAL ASPECTS OF MULTIDRUG RESISTANCE: THE ROLE OF THE TRANSPORTERS AT THE MAIN PROTECTION BARRIERS (ABCB1
ABCC1
ABCC2
ABCG2) ON THE BIOAVAILABILITY OF MANY TYPES OF DRUGS AND MEDICATIONS. 13 ABC superfamily transporters at the human blood-brain barrier (Jean-Michel Scherrmann). 14 The role of ABC transporters at the intestinal barrier (Roos L. Oostendorp
Jos H. Beijnen
and Jan H.M. Schellens). 15 Genetic polymorphisms in ABC transporters (Leslie W. Chinn and Deanna L. Kroetz). PERSPECTIVES. INDEX.
GENOME
NORMAL TISSUE EXPRESSION
PHYSIOLOGICAL ASPECT
AND MECHANISM OF ACTION. 1 The P-glycoprotein 170: Just a multidrug resistance protein or a protean molecule (Fabienne Grandjean-Forestier
Christophe Stenger
Jacques Robert
Mireille Verdier
and Marie-Hélène Ratinaud). 2 Multidrug resistance-associated protein (MRP/ABCC proteins) (Mylène Honorat
Charles Dumontet
and Lea Payen). 3 ABCG2: A new challenge in cancer drug resistance (Orsolya Polgar
Robert W. Robey
Kin Wah To
John Deeken
Patricia A. Fetsch
and Susan E. Bates). PART II ABC PROTEINS AND ONCOLOGY: EXPRESSION
DETECTION
AND IMPLICATION OF ABC PROTEINS IN HEMATOLOGICAL MALIGNANCIES AND SOLID TUMORS. 4 Expression
detection
and implication of ABC proteins in acute myeloblastic leukemia (Ollivier Legrand
Ruo-Ping Tang
and Jean-Pierre Marie). 5 ABC proteins and oncology: Expression
detection
and implication of ABC proteins in solid tumors (Jean François Bernaudin
Anne Fajac
Jocelyne Fleury-Feith
Khaldoun Kerrou
and Roger Lacave). PART III ABC PROTEINS AND PATHOGENIC MICROORGANISMS. 6 ABC transporters and resistance to antibiotics (Serge Michalet and Marie-Geneviève Dijoux-Franca). 7 ABC proteins involved in protozoan parasite resistance (Bruno Pradines). PART IV MULTIDRUG RESISTANCE (MDR) MODULATION THROUGH INHIBITION OF ABC TRANSPORTERS: DESIGN OF INHIBITORS AND MECHANISM OF ACTION. 8 Reversal agents for P-glycoprotein-mediated multidrug resistance (Hamid Morjani and Claudie Madoulet). 9 Reversal agents of multidrug resistance mediated by multidrug resistance-associated proteins (MRPs) (Ahcène Boumendjel
Anne Florin
and Jean Boutonnat). 10 Reversal agents for breast cancer resistance protein (BCRP)-mediated multidrug resistance (Jean Boutonnat
Anne Florin
and Ahcène Boumendjel). 11 Strategies to overcome drug resistance in acute and chronic leukemias (Eric Solary
Vincent Ribrag
and Stéphane de Botton). 12 Multidrug resistance reversal in solid tumors (Tatiana Bogush and Jacques Robert). PART V BIOLOGICAL AND CLINICAL ASPECTS OF MULTIDRUG RESISTANCE: THE ROLE OF THE TRANSPORTERS AT THE MAIN PROTECTION BARRIERS (ABCB1
ABCC1
ABCC2
ABCG2) ON THE BIOAVAILABILITY OF MANY TYPES OF DRUGS AND MEDICATIONS. 13 ABC superfamily transporters at the human blood-brain barrier (Jean-Michel Scherrmann). 14 The role of ABC transporters at the intestinal barrier (Roos L. Oostendorp
Jos H. Beijnen
and Jan H.M. Schellens). 15 Genetic polymorphisms in ABC transporters (Leslie W. Chinn and Deanna L. Kroetz). PERSPECTIVES. INDEX.
PREFACE. CONTRIBUTORS. INTRODUCTION: WHAT IS MULTIDRUG RESISTANCE (Jonathan A. Sheps and Victor Ling). PART I ABC PROTEINS: AN OVERVIEW AND DESCRIPTION OF THE STRUCTURE
GENOME
NORMAL TISSUE EXPRESSION
PHYSIOLOGICAL ASPECT
AND MECHANISM OF ACTION. 1 The P-glycoprotein 170: Just a multidrug resistance protein or a protean molecule (Fabienne Grandjean-Forestier
Christophe Stenger
Jacques Robert
Mireille Verdier
and Marie-Hélène Ratinaud). 2 Multidrug resistance-associated protein (MRP/ABCC proteins) (Mylène Honorat
Charles Dumontet
and Lea Payen). 3 ABCG2: A new challenge in cancer drug resistance (Orsolya Polgar
Robert W. Robey
Kin Wah To
John Deeken
Patricia A. Fetsch
and Susan E. Bates). PART II ABC PROTEINS AND ONCOLOGY: EXPRESSION
DETECTION
AND IMPLICATION OF ABC PROTEINS IN HEMATOLOGICAL MALIGNANCIES AND SOLID TUMORS. 4 Expression
detection
and implication of ABC proteins in acute myeloblastic leukemia (Ollivier Legrand
Ruo-Ping Tang
and Jean-Pierre Marie). 5 ABC proteins and oncology: Expression
detection
and implication of ABC proteins in solid tumors (Jean François Bernaudin
Anne Fajac
Jocelyne Fleury-Feith
Khaldoun Kerrou
and Roger Lacave). PART III ABC PROTEINS AND PATHOGENIC MICROORGANISMS. 6 ABC transporters and resistance to antibiotics (Serge Michalet and Marie-Geneviève Dijoux-Franca). 7 ABC proteins involved in protozoan parasite resistance (Bruno Pradines). PART IV MULTIDRUG RESISTANCE (MDR) MODULATION THROUGH INHIBITION OF ABC TRANSPORTERS: DESIGN OF INHIBITORS AND MECHANISM OF ACTION. 8 Reversal agents for P-glycoprotein-mediated multidrug resistance (Hamid Morjani and Claudie Madoulet). 9 Reversal agents of multidrug resistance mediated by multidrug resistance-associated proteins (MRPs) (Ahcène Boumendjel
Anne Florin
and Jean Boutonnat). 10 Reversal agents for breast cancer resistance protein (BCRP)-mediated multidrug resistance (Jean Boutonnat
Anne Florin
and Ahcène Boumendjel). 11 Strategies to overcome drug resistance in acute and chronic leukemias (Eric Solary
Vincent Ribrag
and Stéphane de Botton). 12 Multidrug resistance reversal in solid tumors (Tatiana Bogush and Jacques Robert). PART V BIOLOGICAL AND CLINICAL ASPECTS OF MULTIDRUG RESISTANCE: THE ROLE OF THE TRANSPORTERS AT THE MAIN PROTECTION BARRIERS (ABCB1
ABCC1
ABCC2
ABCG2) ON THE BIOAVAILABILITY OF MANY TYPES OF DRUGS AND MEDICATIONS. 13 ABC superfamily transporters at the human blood-brain barrier (Jean-Michel Scherrmann). 14 The role of ABC transporters at the intestinal barrier (Roos L. Oostendorp
Jos H. Beijnen
and Jan H.M. Schellens). 15 Genetic polymorphisms in ABC transporters (Leslie W. Chinn and Deanna L. Kroetz). PERSPECTIVES. INDEX.
GENOME
NORMAL TISSUE EXPRESSION
PHYSIOLOGICAL ASPECT
AND MECHANISM OF ACTION. 1 The P-glycoprotein 170: Just a multidrug resistance protein or a protean molecule (Fabienne Grandjean-Forestier
Christophe Stenger
Jacques Robert
Mireille Verdier
and Marie-Hélène Ratinaud). 2 Multidrug resistance-associated protein (MRP/ABCC proteins) (Mylène Honorat
Charles Dumontet
and Lea Payen). 3 ABCG2: A new challenge in cancer drug resistance (Orsolya Polgar
Robert W. Robey
Kin Wah To
John Deeken
Patricia A. Fetsch
and Susan E. Bates). PART II ABC PROTEINS AND ONCOLOGY: EXPRESSION
DETECTION
AND IMPLICATION OF ABC PROTEINS IN HEMATOLOGICAL MALIGNANCIES AND SOLID TUMORS. 4 Expression
detection
and implication of ABC proteins in acute myeloblastic leukemia (Ollivier Legrand
Ruo-Ping Tang
and Jean-Pierre Marie). 5 ABC proteins and oncology: Expression
detection
and implication of ABC proteins in solid tumors (Jean François Bernaudin
Anne Fajac
Jocelyne Fleury-Feith
Khaldoun Kerrou
and Roger Lacave). PART III ABC PROTEINS AND PATHOGENIC MICROORGANISMS. 6 ABC transporters and resistance to antibiotics (Serge Michalet and Marie-Geneviève Dijoux-Franca). 7 ABC proteins involved in protozoan parasite resistance (Bruno Pradines). PART IV MULTIDRUG RESISTANCE (MDR) MODULATION THROUGH INHIBITION OF ABC TRANSPORTERS: DESIGN OF INHIBITORS AND MECHANISM OF ACTION. 8 Reversal agents for P-glycoprotein-mediated multidrug resistance (Hamid Morjani and Claudie Madoulet). 9 Reversal agents of multidrug resistance mediated by multidrug resistance-associated proteins (MRPs) (Ahcène Boumendjel
Anne Florin
and Jean Boutonnat). 10 Reversal agents for breast cancer resistance protein (BCRP)-mediated multidrug resistance (Jean Boutonnat
Anne Florin
and Ahcène Boumendjel). 11 Strategies to overcome drug resistance in acute and chronic leukemias (Eric Solary
Vincent Ribrag
and Stéphane de Botton). 12 Multidrug resistance reversal in solid tumors (Tatiana Bogush and Jacques Robert). PART V BIOLOGICAL AND CLINICAL ASPECTS OF MULTIDRUG RESISTANCE: THE ROLE OF THE TRANSPORTERS AT THE MAIN PROTECTION BARRIERS (ABCB1
ABCC1
ABCC2
ABCG2) ON THE BIOAVAILABILITY OF MANY TYPES OF DRUGS AND MEDICATIONS. 13 ABC superfamily transporters at the human blood-brain barrier (Jean-Michel Scherrmann). 14 The role of ABC transporters at the intestinal barrier (Roos L. Oostendorp
Jos H. Beijnen
and Jan H.M. Schellens). 15 Genetic polymorphisms in ABC transporters (Leslie W. Chinn and Deanna L. Kroetz). PERSPECTIVES. INDEX.